FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change ...
The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
Commonly reported side effects included fever, runny nose, congestion and sore throat. “Today’s approval of the first influenza vaccine for self- or caregiver-administration provides a new option for ...
The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a ...